{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:59:06Z","timestamp":1792069146126,"version":"4.4.0"},"reference-count":127,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Research and Development Program of Science and Technology Department of Sichuan Province","award":["2022YFS0617"],"award-info":[{"award-number":["2022YFS0617"]}]},{"name":"the Key Research and Development Program of Science and Technology Department of Sichuan Province","award":["2022YFS0612"],"award-info":[{"award-number":["2022YFS0612"]}]},{"name":"the Key Research and Development Program of Science and Technology Department of Sichuan Province","award":["2022YFS0612"],"award-info":[{"award-number":["2022YFS0612"]}]},{"name":"grants from the National Natural Science Foundation of China","award":["82170834"],"award-info":[{"award-number":["82170834"]}]},{"name":"the China International medical foundation","award":["Z-2017-26-2202-4"],"award-info":[{"award-number":["Z-2017-26-2202-4"]}]},{"name":"the Office of Science Technology and Talent Work of Luzhou","award":["2020LZXNYDP02"],"award-info":[{"award-number":["2020LZXNYDP02"]}]},{"name":"the Project of Southwest Medical University","award":["2022QN059"],"award-info":[{"award-number":["2022QN059"]}]},{"name":"Graduate Education and Teaching Program of Southwest Medical University","award":["YJG202291"],"award-info":[{"award-number":["YJG202291"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04019-0","type":"journal-article","created":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T09:35:12Z","timestamp":1741340112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Ketogenic diets and \u03b2-hydroxybutyrate in the prevention and treatment of diabetic kidney disease: current progress and future perspectives"],"prefix":"10.1186","volume":"26","author":[{"given":"Junle","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanhong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianshi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changfang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuojun","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pijun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,7]]},"reference":[{"issue":"10397","key":"4019_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2023","unstructured":"Ong KL, Stafford LK, McLaughlin SA, Boyko EJ, Vollset SE, Smith AE, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the global burden of disease study 2021. The Lancet. 2023;402(10397):203\u201334. https:\/\/doi.org\/10.1016\/S0140-6736(23)01301-6.","journal-title":"The Lancet"},{"issue":"5","key":"4019_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/1753-0407.12521","volume":"9","author":"Y Shi","year":"2017","unstructured":"Shi Y, Vanhoutte PM. Macro- and microvascular endothelial dysfunction in diabetes. J Diabetes. 2017;9(5):434\u201349. https:\/\/doi.org\/10.1111\/1753-0407.12521.","journal-title":"J Diabetes"},{"issue":"Suppl 1","key":"4019_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","volume":"22","author":"NM Selby","year":"2020","unstructured":"Selby NM, Taal MW. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22(Suppl 1):3\u201315. https:\/\/doi.org\/10.1111\/dom.14007.","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"4019_CR4","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.3390\/nu13051654","volume":"13","author":"K Dowis","year":"2021","unstructured":"Dowis K, Banga S. The potential health benefits of the ketogenic diet: a narrative review. Nutrients. 2021;13(5):1654. https:\/\/doi.org\/10.3390\/nu13051654.","journal-title":"Nutrients"},{"issue":"5","key":"4019_CR5","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/nu11050962","volume":"11","author":"AM Bolla","year":"2019","unstructured":"Bolla AM, Caretto A, Laurenzi A, Scavini M, Piemonti L. Low-carb and ketogenic diets in type 1 and type 2 diabetes. Nutrients. 2019;11(5):962. https:\/\/doi.org\/10.3390\/nu11050962.","journal-title":"Nutrients"},{"issue":"3","key":"4019_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s11154-020-09580-7","volume":"21","author":"FF Casanueva","year":"2020","unstructured":"Casanueva FF, Castellana M, Bellido D, Trimboli P, Castro AI, Sajoux I, et al. Ketogenic diets as treatment of obesity and type 2 diabetes mellitus. Rev Endocr Metab Disord. 2020;21(3):381\u201397. https:\/\/doi.org\/10.1007\/s11154-020-09580-7.","journal-title":"Rev Endocr Metab Disord"},{"issue":"2","key":"4019_CR7","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/advances\/nmab131","volume":"13","author":"L Pickel","year":"2022","unstructured":"Pickel L, Iliuta IA, Scholey J, Pei Y, Sung HK. Dietary interventions in autosomal dominant polycystic kidney disease. Adv Nutr. 2022;13(2):652\u201366. https:\/\/doi.org\/10.1093\/advances\/nmab131.","journal-title":"Adv Nutr"},{"issue":"4","key":"4019_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018604","volume":"6","author":"MM Poplawski","year":"2011","unstructured":"Poplawski MM, Mastaitis JW, Isoda F, Grosjean F, Zheng F, Mobbs CV, et al. Reversal of diabetic nephropathy by a ketogenic diet. PLoS ONE. 2011;6(4): e18604. https:\/\/doi.org\/10.1371\/journal.pone.0018604.","journal-title":"PLoS ONE"},{"issue":"2","key":"4019_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/antiox11020381","volume":"11","author":"J Jung","year":"2022","unstructured":"Jung J, Park WY, Kim YJ, Kim M, Choe M, Jin K, et al. 3-hydroxybutyrate ameliorates the progression of diabetic nephropathy. Antioxidants (Basel). 2022;11(2):381. https:\/\/doi.org\/10.3390\/antiox11020381.","journal-title":"Antioxidants (Basel)"},{"issue":"12","key":"4019_CR10","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1007\/s00592-020-01552-2","volume":"57","author":"W Luo","year":"2020","unstructured":"Luo W, Yu Y, Wang H, Liu K, Wang Y, Huang M, et al. Up-regulation of mmp-2 by histone h3k9 beta-hydroxybutyrylation to antagonize glomerulosclerosis in diabetic rat. Acta Diabetol. 2020;57(12):1501\u20139. https:\/\/doi.org\/10.1007\/s00592-020-01552-2.","journal-title":"Acta Diabetol"},{"key":"4019_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.yebeh.2019.03.018","volume":"94","author":"S Hohn","year":"2019","unstructured":"Hohn S, Dozieres-Puyravel B, Auvin S. History of dietary treatment: guelpa & marie first report of intermittent fasting for epilepsy in 1911. Epilepsy Behav. 2019;94:277\u201380. https:\/\/doi.org\/10.1016\/j.yebeh.2019.03.018.","journal-title":"Epilepsy Behav"},{"key":"4019_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1167.2008.01821.x","author":"JW Wheless","year":"2008","unstructured":"Wheless JW. History of the ketogenic diet. Epilepsia. 2008. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01821.x.","journal-title":"Epilepsia"},{"issue":"7","key":"4019_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.4140\/TCP.n.2017.388","volume":"32","author":"T Walczyk","year":"2017","unstructured":"Walczyk T, Wick JY. The ketogenic diet: making a comeback. Consult Pharm. 2017;32(7):388\u201396. https:\/\/doi.org\/10.4140\/TCP.n.2017.388.","journal-title":"Consult Pharm"},{"issue":"3","key":"4019_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/s0920-1211(01)00315-1","volume":"48","author":"G Coppola","year":"2002","unstructured":"Coppola G, Veggiotti P, Cusmai R, Bertoli S, Cardinali S, Dionisi-Vici C, et al. The ketogenic diet in children, adolescents and young adults with refractory epilepsy: an italian multicentric experience. Epilepsy Res. 2002;48(3):221\u20137. https:\/\/doi.org\/10.1016\/s0920-1211(01)00315-1.","journal-title":"Epilepsy Res"},{"issue":"2","key":"4019_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/s0887-8994(99)00045-4","volume":"21","author":"AM Hassan","year":"1999","unstructured":"Hassan AM, Keene DL, Whiting SE, Jacob PJ, Champagne JR, Humphreys P. Ketogenic diet in the treatment of refractory epilepsy in childhood. Pediatr Neurol. 1999;21(2):548\u201352. https:\/\/doi.org\/10.1016\/s0887-8994(99)00045-4.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"4019_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/epi4.12225","volume":"3","author":"EH Kossoff","year":"2018","unstructured":"Kossoff EH, Zupec-Kania BA, Auvin S, Ballaban-Gil KR, Christina BA, Blackford R, et al. Optimal clinical management of children receiving dietary therapies for epilepsy: updated recommendations of the international ketogenic diet study group. Epilepsia Open. 2018;3(2):175\u201392. https:\/\/doi.org\/10.1002\/epi4.12225.","journal-title":"Epilepsia Open"},{"issue":"1","key":"4019_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.4103\/2319-4170.107154","volume":"36","author":"Y Liu","year":"2013","unstructured":"Liu Y, Wang H. Medium-chain triglyceride ketogenic diet, an effective treatment for drug-resistant epilepsy and a comparison with other ketogenic diets. Biomed J. 2013;36(1):9. https:\/\/doi.org\/10.4103\/2319-4170.107154.","journal-title":"Biomed J"},{"issue":"1","key":"4019_CR18","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41392-021-00831-w","volume":"7","author":"H Zhu","year":"2022","unstructured":"Zhu H, Bi D, Zhang Y, Kong C, Du J, Wu X, et al. Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementations. Signal Transduct Target Ther. 2022;7(1):11. https:\/\/doi.org\/10.1038\/s41392-021-00831-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"8","key":"4019_CR19","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1177\/0883073813487596","volume":"28","author":"CV Mobbs","year":"2013","unstructured":"Mobbs CV, Mastaitis J, Isoda F, Poplawski M. Treatment of diabetes and diabetic complications with a ketogenic diet. J Child Neurol. 2013;28(8):1009\u201314. https:\/\/doi.org\/10.1177\/0883073813487596.","journal-title":"J Child Neurol"},{"issue":"16","key":"4019_CR20","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.3390\/ijms20163892","volume":"20","author":"M Rusek","year":"2019","unstructured":"Rusek M, Pluta R, U\u0142amek-Kozio\u0142 M, Czuczwar SJ. Ketogenic diet in alzheimer\u2019s disease. Int J Mol Sci. 2019;20(16):3892. https:\/\/doi.org\/10.3390\/ijms20163892.","journal-title":"Int J Mol Sci"},{"issue":"18","key":"4019_CR21","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.3390\/nu14183842","volume":"14","author":"EI Yakupova","year":"2022","unstructured":"Yakupova EI, Bocharnikov AD, Plotnikov EY. Effects of ketogenic diet on muscle metabolism in health and disease. Nutrients. 2022;14(18):3842. https:\/\/doi.org\/10.3390\/nu14183842.","journal-title":"Nutrients"},{"key":"4019_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1743-7075-2-35","volume":"2","author":"JC Mavropoulos","year":"2005","unstructured":"Mavropoulos JC, Yancy WS, Hepburn J, Westman EC. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr Metab (Lond). 2005;2:35. https:\/\/doi.org\/10.1186\/1743-7075-2-35.","journal-title":"Nutr Metab (Lond)"},{"issue":"2","key":"4019_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/MCO.0000000000000540","volume":"22","author":"RJ Klement","year":"2019","unstructured":"Klement RJ. The emerging role of ketogenic diets in cancer treatment. Curr Opin Clin Nutr Metab Care. 2019;22(2):129\u201334. https:\/\/doi.org\/10.1097\/MCO.0000000000000540.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"4019_CR24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnut.2019.00063","volume":"6","author":"NG Norwitz","year":"2019","unstructured":"Norwitz NG, Hu MT, Clarke K. The mechanisms by which the ketone body d-\u03b2-hydroxybutyrate may improve the multiple cellular pathologies of parkinson\u2019s disease. Front Nutr. 2019;6:63. https:\/\/doi.org\/10.3389\/fnut.2019.00063.","journal-title":"Front Nutr"},{"issue":"5\u20136","key":"4019_CR25","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1159\/000499563","volume":"40","author":"TR Wood","year":"2018","unstructured":"Wood TR, Stubbs BJ, Juul SE. Exogenous ketone bodies as promising neuroprotective agents for developmental brain injury. Dev Neurosci. 2018;40(5\u20136):451\u201362. https:\/\/doi.org\/10.1159\/000499563.","journal-title":"Dev Neurosci"},{"issue":"6","key":"4019_CR26","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.3390\/nu12061809","volume":"12","author":"J Wells","year":"2020","unstructured":"Wells J, Swaminathan A, Paseka J, Hanson C. Efficacy and safety of a ketogenic diet in children and adolescents with refractory epilepsy-a review. Nutrients. 2020;12(6):1809. https:\/\/doi.org\/10.3390\/nu12061809.","journal-title":"Nutrients"},{"issue":"6","key":"4019_CR27","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12519-017-0053-2","volume":"13","author":"QY Cai","year":"2017","unstructured":"Cai QY, Zhou ZJ, Luo R, Gan J, Li SP, Mu DZ, et al. Safety and tolerability of the ketogenic diet used for the treatment of refractory childhood epilepsy: a systematic review of published prospective studies. World J Pediatr. 2017;13(6):528\u201336. https:\/\/doi.org\/10.1007\/s12519-017-0053-2.","journal-title":"World J Pediatr"},{"key":"4019_CR28","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.pediatrneurol.2017.01.007","volume":"68","author":"A Lin","year":"2017","unstructured":"Lin A, Turner Z, Doerrer SC, Stanfield A, Kossoff EH. Complications during ketogenic diet initiation: prevalence, treatment, and influence on seizure outcomes. Pediatr Neurol. 2017;68:35\u20139. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2017.01.007.","journal-title":"Pediatr Neurol"},{"issue":"1","key":"4019_CR29","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ejpn.2018.11.007","volume":"23","author":"O Guzel","year":"2019","unstructured":"Guzel O, Uysal U, Arslan N. Efficacy and tolerability of olive oil-based ketogenic diet in children with drug-resistant epilepsy: a single center experience from turkey. Eur J Paediatr Neurol. 2019;23(1):143\u201351. https:\/\/doi.org\/10.1016\/j.ejpn.2018.11.007.","journal-title":"Eur J Paediatr Neurol"},{"issue":"12","key":"4019_CR30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1017\/S0012162206002143","volume":"48","author":"DK Groesbeck","year":"2006","unstructured":"Groesbeck DK, Bluml RM, Kossoff EH. Long-term use of the ketogenic diet in the treatment of epilepsy. Dev Med Child Neurol. 2006;48(12):978\u201381. https:\/\/doi.org\/10.1017\/S0012162206002143.","journal-title":"Dev Med Child Neurol"},{"issue":"6","key":"4019_CR31","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1542\/peds.102.6.1358","volume":"102","author":"JM Freeman","year":"1998","unstructured":"Freeman JM, Vining EP, Pillas DJ, Pyzik PL, Casey JC, Kelly LM. The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics. 1998;102(6):1358\u201363. https:\/\/doi.org\/10.1542\/peds.102.6.1358.","journal-title":"Pediatrics"},{"issue":"2","key":"4019_CR32","doi-asserted-by":"publisher","first-page":"e300","DOI":"10.1542\/peds.2009-0217","volume":"124","author":"MA McNally","year":"2009","unstructured":"McNally MA, Pyzik PL, Rubenstein JE, Hamdy RF, Kossoff EH. Empiric use of potassium citrate reduces kidney-stone incidence with the ketogenic diet. Pediatrics. 2009;124(2):e300\u20134. https:\/\/doi.org\/10.1542\/peds.2009-0217.","journal-title":"Pediatrics"},{"key":"4019_CR33","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.eplepsyres.2017.07.014","volume":"136","author":"PJ Simm","year":"2017","unstructured":"Simm PJ, Bicknell-Royle J, Lawrie J, Nation J, Draffin K, Stewart KG, et al. The effect of the ketogenic diet on the developing skeleton. Epilepsy Res. 2017;136:62\u20136. https:\/\/doi.org\/10.1016\/j.eplepsyres.2017.07.014.","journal-title":"Epilepsy Res"},{"issue":"4","key":"4019_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.ejpn.2019.04.001","volume":"23","author":"A Svedlund","year":"2019","unstructured":"Svedlund A, Hallbook T, Magnusson P, Dahlgren J, Swolin-Eide D. Prospective study of growth and bone mass in swedish children treated with the modified atkins diet. Eur J Paediatr Neurol. 2019;23(4):629\u201338. https:\/\/doi.org\/10.1016\/j.ejpn.2019.04.001.","journal-title":"Eur J Paediatr Neurol"},{"issue":"3","key":"4019_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/s0002-8223(02)90093-3","volume":"102","author":"S Williams","year":"2002","unstructured":"Williams S, Basualdo-Hammond C, Curtis R, Schuller R. Growth retardation in children with epilepsy on the ketogenic diet: a retrospective chart review. J Am Diet Assoc. 2002;102(3):405\u20137. https:\/\/doi.org\/10.1016\/s0002-8223(02)90093-3.","journal-title":"J Am Diet Assoc"},{"issue":"6","key":"4019_CR36","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.3945\/ajcn.2008.26099","volume":"88","author":"AG Bergqvist","year":"2008","unstructured":"Bergqvist AG, Schall JI, Stallings VA, Zemel BS. Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet. Am J Clin Nutr. 2008;88(6):1678\u201384. https:\/\/doi.org\/10.3945\/ajcn.2008.26099.","journal-title":"Am J Clin Nutr"},{"issue":"20","key":"4019_CR37","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1016\/j.biomaterials.2007.03.003","volume":"28","author":"Y Zhao","year":"2007","unstructured":"Zhao Y, Zou B, Shi Z, Wu Q, Chen GQ. The effect of 3-hydroxybutyrate on the in vitro differentiation of murine osteoblast mc3t3-e1 and in vivo bone formation in ovariectomized rats. Biomaterials. 2007;28(20):3063\u201373. https:\/\/doi.org\/10.1016\/j.biomaterials.2007.03.003.","journal-title":"Biomaterials"},{"issue":"28","key":"4019_CR38","doi-asserted-by":"publisher","first-page":"8273","DOI":"10.1016\/j.biomaterials.2014.06.020","volume":"35","author":"Q Cao","year":"2014","unstructured":"Cao Q, Zhang J, Liu H, Wu Q, Chen J, Chen GQ. The mechanism of anti-osteoporosis effects of 3-hydroxybutyrate and derivatives under simulated microgravity. Biomaterials. 2014;35(28):8273\u201383. https:\/\/doi.org\/10.1016\/j.biomaterials.2014.06.020.","journal-title":"Biomaterials"},{"issue":"1","key":"4019_CR39","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12916-021-02185-0","volume":"19","author":"H Kolb","year":"2021","unstructured":"Kolb H, Kempf K, Rohling M, Lenzen-Schulte M, Schloot NC, Martin S. Ketone bodies: from enemy to friend and guardian angel. Bmc Med. 2021;19(1):313. https:\/\/doi.org\/10.1186\/s12916-021-02185-0.","journal-title":"Bmc Med"},{"issue":"4","key":"4019_CR40","doi-asserted-by":"publisher","first-page":"782","DOI":"10.3390\/nu14040782","volume":"14","author":"M Murakami","year":"2022","unstructured":"Murakami M, Tognini P. Molecular mechanisms underlying the bioactive properties of a ketogenic diet. Nutrients. 2022;14(4):782. https:\/\/doi.org\/10.3390\/nu14040782.","journal-title":"Nutrients"},{"issue":"4","key":"4019_CR41","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10741-020-10065-7","volume":"26","author":"Y Hattori","year":"2021","unstructured":"Hattori Y. Beneficial effects on kidney during treatment with sodium-glucose cotransporter 2 inhibitors: proposed role of ketone utilization. Heart Fail Rev. 2021;26(4):947\u201352. https:\/\/doi.org\/10.1007\/s10741-020-10065-7.","journal-title":"Heart Fail Rev"},{"key":"4019_CR42","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/474296","volume":"2014","author":"A Paoli","year":"2014","unstructured":"Paoli A, Bianco A, Damiani E, Bosco G. Ketogenic diet in neuromuscular and neurodegenerative diseases. Biomed Res Int. 2014;2014: 474296. https:\/\/doi.org\/10.1155\/2014\/474296.","journal-title":"Biomed Res Int"},{"issue":"2","key":"4019_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","volume":"25","author":"P Puchalska","year":"2017","unstructured":"Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017;25(2):262\u201384. https:\/\/doi.org\/10.1016\/j.cmet.2016.12.022.","journal-title":"Cell Metab"},{"issue":"6","key":"4019_CR44","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.12182\/20231160202","volume":"54","author":"Y Liu","year":"2023","unstructured":"Liu Y, Ma L, Fu P. Ketone body metabolism and renal diseases. Sichuan Da Xue Xue Bao Yi Xue Ban. 2023;54(6):1091\u20136. https:\/\/doi.org\/10.12182\/20231160202.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"4019_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.981285","volume":"13","author":"T Zhou","year":"2022","unstructured":"Zhou T, Cheng X, He Y, Xie Y, Xu F, Xu Y, et al. Function and mechanism of histone beta-hydroxybutyrylation in health and disease. Front Immunol. 2022;13: 981285. https:\/\/doi.org\/10.3389\/fimmu.2022.981285.","journal-title":"Front Immunol"},{"issue":"4","key":"4019_CR46","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1203\/00006450-199710000-00013","volume":"42","author":"T Fukao","year":"1997","unstructured":"Fukao T, Song XQ, Mitchell GA, Yamaguchi S, Sukegawa K, Orii T, et al. Enzymes of ketone body utilization in human tissues: protein and messenger rna levels of succinyl-coenzyme a (coa):3-ketoacid coa transferase and mitochondrial and cytosolic acetoacetyl-coa thiolases. Pediatr Res. 1997;42(4):498\u2013502. https:\/\/doi.org\/10.1203\/00006450-199710000-00013.","journal-title":"Pediatr Res"},{"issue":"1","key":"4019_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.tem.2013.09.002","volume":"25","author":"JC Newman","year":"2014","unstructured":"Newman JC, Verdin E. Ketone bodies as signaling metabolites. Trends Endocrinol Metab. 2014;25(1):42\u201352. https:\/\/doi.org\/10.1016\/j.tem.2013.09.002.","journal-title":"Trends Endocrinol Metab"},{"key":"4019_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-nutr-071816-064916","volume":"37","author":"JC Newman","year":"2017","unstructured":"Newman JC, Verdin E. Beta-hydroxybutyrate: a signaling metabolite. Annu Rev Nutr. 2017;37:51\u201376. https:\/\/doi.org\/10.1146\/annurev-nutr-071816-064916.","journal-title":"Annu Rev Nutr"},{"issue":"3","key":"4019_CR49","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13668-018-0235-0","volume":"7","author":"VM Gershuni","year":"2018","unstructured":"Gershuni VM, Yan SL, Medici V. Nutritional ketosis for weight management and reversal of metabolic syndrome. Curr Nutr Rep. 2018;7(3):97\u2013106. https:\/\/doi.org\/10.1007\/s13668-018-0235-0.","journal-title":"Curr Nutr Rep"},{"issue":"11","key":"4019_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e21098","volume":"9","author":"Y He","year":"2023","unstructured":"He Y, Cheng X, Zhou T, Li D, Peng J, Xu Y, et al. \u0392-hydroxybutyrate as an epigenetic modifier: underlying mechanisms and implications. Heliyon. 2023;9(11): e21098. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e21098.","journal-title":"Heliyon"},{"issue":"17","key":"4019_CR51","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1016\/j.molcel.2023.07.030","volume":"83","author":"C Zhao","year":"2023","unstructured":"Zhao C, Wang H, Liu Y, Cheng L, Wang B, Tian X, et al. Biased allosteric activation of ketone body receptor hcar2 suppresses inflammation. Mol Cell. 2023;83(17):3171\u201387. https:\/\/doi.org\/10.1016\/j.molcel.2023.07.030.","journal-title":"Mol Cell"},{"issue":"1","key":"4019_CR52","doi-asserted-by":"publisher","first-page":"F106","DOI":"10.1152\/ajprenal.00126.2009","volume":"297","author":"KH Cho","year":"2009","unstructured":"Cho KH, Kim HJ, Rodriguez-Iturbe B, Vaziri ND. Niacin ameliorates oxidative stress, inflammation, proteinuria, and hypertension in rats with chronic renal failure. Am J Physiol Renal Physiol. 2009;297(1):F106\u201313. https:\/\/doi.org\/10.1152\/ajprenal.00126.2009.","journal-title":"Am J Physiol Renal Physiol"},{"key":"4019_CR53","doi-asserted-by":"publisher","first-page":"3944","DOI":"10.1038\/ncomms4944","volume":"5","author":"M Rahman","year":"2014","unstructured":"Rahman M, Muhammad S, Khan MA, Chen H, Ridder DA, Muller-Fielitz H, et al. The beta-hydroxybutyrate receptor hca2 activates a neuroprotective subset of macrophages. Nat Commun. 2014;5:3944. https:\/\/doi.org\/10.1038\/ncomms4944.","journal-title":"Nat Commun"},{"issue":"19","key":"4019_CR54","doi-asserted-by":"publisher","first-page":"8030","DOI":"10.1073\/pnas.1016088108","volume":"108","author":"I Kimura","year":"2011","unstructured":"Kimura I, Inoue D, Maeda T, Hara T, Ichimura A, Miyauchi S, et al. Short-chain fatty acids and ketones directly regulate sympathetic nervous system via g protein-coupled receptor 41 (gpr41). Proc Natl Acad Sci U S A. 2011;108(19):8030\u20135. https:\/\/doi.org\/10.1073\/pnas.1016088108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"4019_CR55","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nm.3779","volume":"21","author":"C Tang","year":"2015","unstructured":"Tang C, Ahmed K, Gille A, Lu S, Grone HJ, Tunaru S, et al. Loss of ffa2 and ffa3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nat Med. 2015;21(2):173\u20137. https:\/\/doi.org\/10.1038\/nm.3779.","journal-title":"Nat Med"},{"issue":"3","key":"4019_CR56","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","volume":"21","author":"YH Youm","year":"2015","unstructured":"Youm YH, Nguyen KY, Grant RW, Goldberg EL, Bodogai M, Kim D, et al. The ketone metabolite beta-hydroxybutyrate blocks nlrp3 inflammasome-mediated inflammatory disease. Nat Med. 2015;21(3):263\u20139. https:\/\/doi.org\/10.1038\/nm.3804.","journal-title":"Nat Med"},{"issue":"23","key":"4019_CR57","doi-asserted-by":"publisher","first-page":"14564","DOI":"10.3390\/ijms232314564","volume":"23","author":"N Bendridi","year":"2022","unstructured":"Bendridi N, Selmi A, Balcerczyk A, Pirola L. Ketone bodies as metabolites and signalling molecules at the crossroad between inflammation and epigenetic control of cardiometabolic disorders. Int J Mol Sci. 2022;23(23):14564. https:\/\/doi.org\/10.3390\/ijms232314564.","journal-title":"Int J Mol Sci"},{"issue":"41","key":"4019_CR58","doi-asserted-by":"publisher","first-page":"66444","DOI":"10.18632\/oncotarget.12119","volume":"7","author":"HR Bae","year":"2016","unstructured":"Bae HR, Kim DH, Park MH, Lee B, Kim MJ, Lee EK, et al. Beta-hydroxybutyrate suppresses inflammasome formation by ameliorating endoplasmic reticulum stress via ampk activation. Oncotarget. 2016;7(41):66444\u201354. https:\/\/doi.org\/10.18632\/oncotarget.12119.","journal-title":"Oncotarget"},{"issue":"1","key":"4019_CR59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/j.1474-9726.2009.00532.x","volume":"9","author":"JR Mitchell","year":"2010","unstructured":"Mitchell JR, Verweij M, Brand K, van de Ven M, Goemaere N, van den Engel S, et al. Short-term dietary restriction and fasting precondition against ischemia reperfusion injury in mice. Aging Cell. 2010;9(1):40\u201353. https:\/\/doi.org\/10.1111\/j.1474-9726.2009.00532.x.","journal-title":"Aging Cell"},{"issue":"11","key":"4019_CR60","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.1111\/dom.14503","volume":"23","author":"MN Kim","year":"2021","unstructured":"Kim MN, Moon JH, Cho YM. Sodium-glucose cotransporter-2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body-induced nrf2 activation. Diabetes Obes Metab. 2021;23(11):2561\u201371. https:\/\/doi.org\/10.1111\/dom.14503.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"4019_CR61","doi-asserted-by":"publisher","first-page":"3476","DOI":"10.3168\/jds.2017-13234","volume":"101","author":"X Du","year":"2018","unstructured":"Du X, Zhu Y, Peng Z, Cui Y, Zhang Q, Shi Z, et al. High concentrations of fatty acids and beta-hydroxybutyrate impair the growth hormone-mediated hepatic jak2-stat5 pathway in clinically ketotic cows. J Dairy Sci. 2018;101(4):3476\u201387. https:\/\/doi.org\/10.3168\/jds.2017-13234.","journal-title":"J Dairy Sci"},{"issue":"8","key":"4019_CR62","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1001\/jamaoncol.2022.1769","volume":"8","author":"UA Shah","year":"2022","unstructured":"Shah UA, Iyengar NM. Plant-based and ketogenic diets as diverging paths to address cancer: a review. Jama Oncol. 2022;8(8):1201\u20138. https:\/\/doi.org\/10.1001\/jamaoncol.2022.1769.","journal-title":"Jama Oncol"},{"issue":"12","key":"4019_CR63","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1021\/tx7002036","volume":"20","author":"DG Robertson","year":"2007","unstructured":"Robertson DG, Datta K, Wells D, Egnash L, Robosky L, Manning M, et al. Metabonomic evaluation of metabolic dysregulation in rats induced by pf 376304, a novel inhibitor of phosphoinositide 3-kinase. Chem Res Toxicol. 2007;20(12):1871\u20137. https:\/\/doi.org\/10.1021\/tx7002036.","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"4019_CR64","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1007\/s11033-023-08977-2","volume":"51","author":"F Roohy","year":"2024","unstructured":"Roohy F, Siri M, Kohansal K, Ghalandari A, Rezaei R, Maleki MH, et al. Targeting apoptosis and unfolded protein response: the impact of beta-hydroxybutyrate in clear cell renal cell carcinoma under glucose-deprived conditions. Mol Biol Rep. 2024;51(1):168. https:\/\/doi.org\/10.1007\/s11033-023-08977-2.","journal-title":"Mol Biol Rep"},{"key":"4019_CR65","doi-asserted-by":"publisher","first-page":"601594","DOI":"10.3389\/fendo.2020.601594","volume":"11","author":"Y Fujita","year":"2020","unstructured":"Fujita Y, Atageldiyeva KK, Takeda Y, Yanagimachi T, Makino Y, Haneda M. A low-carbohydrate diet improves glucose metabolism in lean insulinopenic akita mice along with sodium-glucose cotransporter 2 inhibitor. Front Endocrinol (Lausanne). 2020;11:601594. https:\/\/doi.org\/10.3389\/fendo.2020.601594.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"10","key":"4019_CR66","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/jcmm.17744","volume":"27","author":"S Wang","year":"2023","unstructured":"Wang S, Zhou J, Lu J, Lin Y, Liu S, Chen K. A ketogenic diet improves vascular hyperpermeability in type 2 diabetic mice by downregulating vascular pescadillo1 expression. J Cell Mol Med. 2023;27(10):1410\u201322. https:\/\/doi.org\/10.1111\/jcmm.17744.","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4019_CR67","doi-asserted-by":"publisher","first-page":"758","DOI":"10.3390\/nu13030758","volume":"13","author":"E Moriconi","year":"2021","unstructured":"Moriconi E, Camajani E, Fabbri A, Lenzi A, Caprio M. Very-low-calorie ketogenic diet as a safe and valuable tool for long-term glycemic management in patients with obesity and type 2 diabetes. Nutrients. 2021;13(3):758. https:\/\/doi.org\/10.3390\/nu13030758.","journal-title":"Nutrients"},{"issue":"2","key":"4019_CR68","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88\u201398. https:\/\/doi.org\/10.1038\/nrendo.2017.151.","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"4019_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.13140","volume":"44","author":"RJ Li","year":"2020","unstructured":"Li RJ, Liu Y, Liu HQ, Li J. Ketogenic diets and protective mechanisms in epilepsy, metabolic disorders, cancer, neuronal loss, and muscle and nerve degeneration. J Food Biochem. 2020;44(3): e13140. https:\/\/doi.org\/10.1111\/jfbc.13140.","journal-title":"J Food Biochem"},{"issue":"3","key":"4019_CR70","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3945\/ajcn.2009.27834","volume":"90","author":"MA Veldhorst","year":"2009","unstructured":"Veldhorst MA, Westerterp-Plantenga MS, Westerterp KR. Gluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet. Am J Clin Nutr. 2009;90(3):519\u201326. https:\/\/doi.org\/10.3945\/ajcn.2009.27834.","journal-title":"Am J Clin Nutr"},{"key":"4019_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.843520","volume":"13","author":"ER Kim","year":"2022","unstructured":"Kim ER, Kim SR, Cho W, Lee SG, Kim SH, Kim JH, et al. Short term isocaloric ketogenic diet modulates nlrp3 inflammasome via b-hydroxybutyrate and fibroblast growth factor 21. Front Immunol. 2022;13: 843520. https:\/\/doi.org\/10.3389\/fimmu.2022.843520.","journal-title":"Front Immunol"},{"issue":"9","key":"4019_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2016.36","volume":"6","author":"A Goday","year":"2016","unstructured":"Goday A, Bellido D, Sajoux I, Crujeiras AB, Burguera B, Garc\u00eda-Luna PP, et al. Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr Diabetes. 2016;6(9): e230. https:\/\/doi.org\/10.1038\/nutd.2016.36.","journal-title":"Nutr Diabetes"},{"issue":"3","key":"4019_CR73","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1093\/ajcn\/nqac154","volume":"116","author":"CD Gardner","year":"2022","unstructured":"Gardner CD, Landry MJ, Perelman D, Petlura C, Durand LR, Aronica L, et al. Effect of a ketogenic diet versus mediterranean diet on glycated hemoglobin in individuals with prediabetes and type 2 diabetes mellitus: the interventional keto-med randomized crossover trial. Am J Clin Nutr. 2022;116(3):640\u201352. https:\/\/doi.org\/10.1093\/ajcn\/nqac154.","journal-title":"Am J Clin Nutr"},{"issue":"16","key":"4019_CR74","doi-asserted-by":"publisher","first-page":"10429","DOI":"10.3390\/ijerph191610429","volume":"19","author":"C Zhou","year":"2022","unstructured":"Zhou C, Wang M, Liang J, He G, Chen N. Ketogenic diet benefits to weight loss, glycemic control, and lipid profiles in overweight patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled trails. Int J Environ Res Public Health. 2022;19(16):10429. https:\/\/doi.org\/10.3390\/ijerph191610429.","journal-title":"Int J Environ Res Public Health"},{"issue":"12","key":"4019_CR75","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1111\/dom.14837","volume":"24","author":"A Parry Strong","year":"2022","unstructured":"Parry Strong A, Wright McNaughton M, Weatherall M, Hall RM, Coppell KJ, Barthow C, et al. Very low carbohydrate (ketogenic) diets in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2022;24(12):2431\u201342. https:\/\/doi.org\/10.1111\/dom.14837.","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"4019_CR76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0091027","volume":"9","author":"LR Saslow","year":"2014","unstructured":"Saslow LR, Kim S, Daubenmier JJ, Moskowitz JT, Phinney SD, Goldman V, et al. A randomized pilot trial of a moderate carbohydrate diet compared to a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes. PLoS ONE. 2014;9(4): e91027. https:\/\/doi.org\/10.1371\/journal.pone.0091027.","journal-title":"PLoS ONE"},{"issue":"5","key":"4019_CR77","doi-asserted-by":"publisher","first-page":"E552","DOI":"10.1152\/ajpendo.00453.2013","volume":"306","author":"JH Ellenbroek","year":"2014","unstructured":"Ellenbroek JH, van Dijck L, T\u00f6ns HA, Rabelink TJ, Carlotti F, Ballieux BEPB, et al. Long-term ketogenic diet causes glucose intolerance and reduced \u03b2- and \u03b1-cell mass but no weight loss in mice. Am J Physiol Endocrinol Metab. 2014;306(5):E552\u20138. https:\/\/doi.org\/10.1152\/ajpendo.00453.2013.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"4019_CR78","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mcna.2012.10.010","volume":"97","author":"C Maric-Bilkan","year":"2013","unstructured":"Maric-Bilkan C. Obesity and diabetic kidney disease. Med Clin North Am. 2013;97(1):59\u201374. https:\/\/doi.org\/10.1016\/j.mcna.2012.10.010.","journal-title":"Med Clin North Am"},{"issue":"9","key":"4019_CR79","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s11886-022-01731-3","volume":"24","author":"CF Kirkpatrick","year":"2022","unstructured":"Kirkpatrick CF, Willard K, Maki KC. Keto is trending: implications for body weight and lipid management. Curr Cardiol Rep. 2022;24(9):1093\u2013100. https:\/\/doi.org\/10.1007\/s11886-022-01731-3.","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"4019_CR80","doi-asserted-by":"publisher","first-page":"780","DOI":"10.3945\/ajcn.115.112581","volume":"102","author":"J Tay","year":"2015","unstructured":"Tay J, Luscombe-Marsh ND, Thompson CH, Noakes M, Buckley JD, Wittert GA, et al. Comparison of low- and high-carbohydrate diets for type 2 diabetes management: a randomized trial. Am J Clin Nutr. 2015;102(4):780\u201390. https:\/\/doi.org\/10.3945\/ajcn.115.112581.","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"4019_CR81","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/j.nut.2012.01.016","volume":"28","author":"TA Hussain","year":"2012","unstructured":"Hussain TA, Mathew TC, Dashti AA, Asfar S, Al-Zaid N, Dashti HM. Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes. Nutrition. 2012;28(10):1016\u201321. https:\/\/doi.org\/10.1016\/j.nut.2012.01.016.","journal-title":"Nutrition"},{"issue":"12","key":"4019_CR82","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41387-017-0006-9","volume":"7","author":"LR Saslow","year":"2017","unstructured":"Saslow LR, Daubenmier JJ, Moskowitz JT, Kim S, Murphy EJ, Phinney SD, et al. Twelve-month outcomes of a randomized trial of a moderate-carbohydrate versus very low-carbohydrate diet in overweight adults with type 2 diabetes mellitus or prediabetes. Nutr Diabetes. 2017;7(12):304. https:\/\/doi.org\/10.1038\/s41387-017-0006-9.","journal-title":"Nutr Diabetes"},{"issue":"1","key":"4019_CR83","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1743-7075-2-34","volume":"2","author":"WS Yancy","year":"2005","unstructured":"Yancy WS, Foy M, Chalecki AM, Vernon MC, Westman EC. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond). 2005;2(1):34. https:\/\/doi.org\/10.1186\/1743-7075-2-34.","journal-title":"Nutr Metab (Lond)"},{"issue":"2","key":"4019_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2016.2","volume":"6","author":"BJ Lamont","year":"2016","unstructured":"Lamont BJ, Waters MF, Andrikopoulos S. A low-carbohydrate high-fat diet increases weight gain and does not improve glucose tolerance, insulin secretion or \u03b2-cell mass in nzo mice. Nutr Diabetes. 2016;6(2): e194. https:\/\/doi.org\/10.1038\/nutd.2016.2.","journal-title":"Nutr Diabetes"},{"issue":"5","key":"4019_CR85","doi-asserted-by":"publisher","first-page":"E1197","DOI":"10.1152\/ajpendo.00357.2009","volume":"297","author":"MK Badman","year":"2009","unstructured":"Badman MK, Kennedy AR, Adams AC, Pissios P, Maratos-Flier E. A very low carbohydrate ketogenic diet improves glucose tolerance in ob\/ob mice independently of weight loss. Am J Physiol Endocrinol Metab. 2009;297(5):E1197\u2013204. https:\/\/doi.org\/10.1152\/ajpendo.00357.2009.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"5","key":"4019_CR86","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.jacl.2019.08.003","volume":"13","author":"CF Kirkpatrick","year":"2019","unstructured":"Kirkpatrick CF, Bolick JP, Kris-Etherton PM, Sikand G, Aspry KE, Soffer DE, et al. Review of current evidence and clinical recommendations on the effects of low-carbohydrate and very-low-carbohydrate (including ketogenic) diets for the management of body weight and other cardiometabolic risk factors: a scientific statement from the national lipid association nutrition and lifestyle task force. J Clin Lipidol. 2019;13(5):689\u2013711. https:\/\/doi.org\/10.1016\/j.jacl.2019.08.003.","journal-title":"J Clin Lipidol"},{"issue":"5","key":"4019_CR87","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.plipres.2008.02.003","volume":"47","author":"JS Volek","year":"2008","unstructured":"Volek JS, Fernandez ML, Feinman RD, Phinney SD. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog Lipid Res. 2008;47(5):307\u201318. https:\/\/doi.org\/10.1016\/j.plipres.2008.02.003.","journal-title":"Prog Lipid Res"},{"issue":"1","key":"4019_CR88","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1467-789X.2006.00222.x","volume":"7","author":"A Adam-Perrot","year":"2006","unstructured":"Adam-Perrot A, Clifton P, Brouns F. Low-carbohydrate diets: nutritional and physiological aspects. Obes Rev. 2006;7(1):49\u201358. https:\/\/doi.org\/10.1111\/j.1467-789X.2006.00222.x.","journal-title":"Obes Rev"},{"issue":"10","key":"4019_CR89","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.amjmed.2020.05.017","volume":"133","author":"MS D'Souza","year":"2020","unstructured":"D\u2019Souza MS, Dong TA, Ragazzo G, Dhindsa DS, Mehta A, Sandesara PB, et al. From fad to fact: evaluating the impact of emerging diets on the prevention of cardiovascular disease. Am J Med. 2020;133(10):1126\u201334. https:\/\/doi.org\/10.1016\/j.amjmed.2020.05.017.","journal-title":"Am J Med"},{"issue":"4","key":"4019_CR90","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S1062-1458(03)00265-4","volume":"12","author":"GD Foster","year":"2003","unstructured":"Foster GD, Wyatt HR, Hill JO. A randomized trial of a low-carbohydrate diet for obesity. ACC Curr J Rev. 2003;12(4):29. https:\/\/doi.org\/10.1016\/S1062-1458(03)00265-4.","journal-title":"ACC Curr J Rev"},{"issue":"8","key":"4019_CR91","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.accreview.2004.07.104","volume":"13","author":"WS Yancy","year":"2004","unstructured":"Yancy WS, Olsen MK, Guyton JR, Bakst RP, Westman EC. A low-carbohydrate, ketogenic diet versus a low-fat diet to treat obesity and hyperlipidemia. ACC Curr J Rev. 2004;13(8):18\u20139. https:\/\/doi.org\/10.1016\/j.accreview.2004.07.104.","journal-title":"ACC Curr J Rev"},{"issue":"1","key":"4019_CR92","doi-asserted-by":"publisher","first-page":"sfad274","DOI":"10.1093\/ckj\/sfad274","volume":"17","author":"S Joshi","year":"2024","unstructured":"Joshi S, Shi R, Patel J. Risks of the ketogenic diet in ckd \u2013 the con part. Clin Kidney J. 2024;17(1):sfad274. https:\/\/doi.org\/10.1093\/ckj\/sfad274.","journal-title":"Clin Kidney J"},{"issue":"2","key":"4019_CR93","doi-asserted-by":"publisher","first-page":"460","DOI":"10.2337\/db07-1119","volume":"57","author":"V Thallas-Bonke","year":"2008","unstructured":"Thallas-Bonke V, Thorpe SR, Coughlan MT, Fukami K, Yap FY, Sourris KC, et al. Inhibition of nadph oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase c-alpha-dependent pathway. Diabetes. 2008;57(2):460\u20139. https:\/\/doi.org\/10.2337\/db07-1119.","journal-title":"Diabetes"},{"key":"4019_CR94","doi-asserted-by":"publisher","unstructured":"Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP. Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol. 2019;70(6). https:\/\/doi.org\/10.26402\/jpp.2019.6.01.","DOI":"10.26402\/jpp.2019.6.01"},{"issue":"1","key":"4019_CR95","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","volume":"87","author":"K Bedard","year":"2007","unstructured":"Bedard K, Krause KH. The nox family of ros-generating nadph oxidases: physiology and pathophysiology. Physiol Rev. 2007;87(1):245\u2013313. https:\/\/doi.org\/10.1152\/physrev.00044.2005.","journal-title":"Physiol Rev"},{"issue":"4","key":"4019_CR96","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.bbrc.2014.04.074","volume":"447","author":"T Wei","year":"2014","unstructured":"Wei T, Tian W, Liu F, Xie G. Protective effects of exogenous \u03b2-hydroxybutyrate on paraquat toxicity in rat kidney. Biochem Biophys Res Commun. 2014;447(4):666\u201371. https:\/\/doi.org\/10.1016\/j.bbrc.2014.04.074.","journal-title":"Biochem Biophys Res Commun"},{"issue":"22","key":"4019_CR97","doi-asserted-by":"publisher","first-page":"13384","DOI":"10.18632\/aging.205248","volume":"15","author":"S Wan","year":"2023","unstructured":"Wan S, Teng F, Fan W, Xu B, Li X, Tan X, et al. Bdh1 mediated \u03b2ohb metabolism ameliorates diabetic kidney disease by activation of nrf2-mediated antioxidative pathway. Aging (Albany, Ny). 2023;15(22):13384\u2013410. https:\/\/doi.org\/10.18632\/aging.205248.","journal-title":"Aging (Albany, Ny.)"},{"issue":"6116","key":"4019_CR98","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1126\/science.1227166","volume":"339","author":"T Shimazu","year":"2013","unstructured":"Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, et al. Suppression of oxidative stress by beta-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339(6116):211\u20134. https:\/\/doi.org\/10.1126\/science.1227166.","journal-title":"Science"},{"key":"4019_CR99","doi-asserted-by":"publisher","first-page":"843520","DOI":"10.3389\/fimmu.2022.843520","volume":"13","author":"ER Kim","year":"2022","unstructured":"Kim ER, Kim SR, Cho W, Lee S, Kim SH, Kim JH, et al. Short term isocaloric ketogenic diet modulates nlrp3 inflammasome via b-hydroxybutyrate and fibroblast growth factor 21. Front Immunol. 2022;13:843520. https:\/\/doi.org\/10.3389\/fimmu.2022.843520.","journal-title":"Front Immunol"},{"issue":"3","key":"4019_CR100","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cmet.2020.06.020","volume":"32","author":"I Tomita","year":"2020","unstructured":"Tomita I, Kume S, Sugahara S, Osawa N, Yamahara K, Yasuda-Yamahara M, et al. Sglt2 inhibition mediates protection from diabetic kidney disease by promoting ketone body-induced mtorc1 inhibition. Cell Metab. 2020;32(3):404\u201319. https:\/\/doi.org\/10.1016\/j.cmet.2020.06.020.","journal-title":"Cell Metab"},{"issue":"2","key":"4019_CR101","doi-asserted-by":"publisher","first-page":"E287","DOI":"10.1152\/ajpendo.00308.2010","volume":"300","author":"D Zhang","year":"2011","unstructured":"Zhang D, Yang H, Kong X, Wang K, Mao X, Yan X, et al. Proteomics analysis reveals diabetic kidney as a ketogenic organ in type 2 diabetes. Am J Physiol Endocrinol Metab. 2011;300(2):E287\u201395. https:\/\/doi.org\/10.1152\/ajpendo.00308.2010.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"6","key":"4019_CR102","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1046\/j.1523-1755.2003.00330.x","volume":"64","author":"JY Guh","year":"2003","unstructured":"Guh JY, Chuang TD, Chen HC, Hung WC, Lai YH, Shin SJ, et al. Beta-hydroxybutyrate-induced growth inhibition and collagen production in hk-2 cells are dependent on tgf-beta and smad3. Kidney Int. 2003;64(6):2041\u201351. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00330.x.","journal-title":"Kidney Int"},{"key":"4019_CR103","doi-asserted-by":"publisher","first-page":"1139444","DOI":"10.3389\/fendo.2023.1139444","volume":"14","author":"YP Han","year":"2023","unstructured":"Han YP, Liu LJ, Yan JL, Chen MY, Meng XF, Zhou XR, et al. Autophagy and its therapeutic potential in diabetic nephropathy. Front Endocrinol (Lausanne). 2023;14:1139444. https:\/\/doi.org\/10.3389\/fendo.2023.1139444.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"4019_CR104","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.kint.2021.06.031","volume":"100","author":"Y Fang","year":"2021","unstructured":"Fang Y, Chen B, Gong AY, Malhotra DK, Gupta R, Dworkin LD, et al. The ketone body \u03b2-hydroxybutyrate mitigates the senescence response of glomerular podocytes to diabetic insults. Kidney Int. 2021;100(5):1037\u201353. https:\/\/doi.org\/10.1016\/j.kint.2021.06.031.","journal-title":"Kidney Int"},{"issue":"8","key":"4019_CR105","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","volume":"24","author":"S Imai","year":"2014","unstructured":"Imai S, Guarente L. Nad+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464\u201371. https:\/\/doi.org\/10.1016\/j.tcb.2014.04.002.","journal-title":"Trends Cell Biol"},{"issue":"7255","key":"4019_CR106","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nature08197","volume":"460","author":"T Finkel","year":"2009","unstructured":"Finkel T, Deng CX, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature. 2009;460(7255):587\u201391. https:\/\/doi.org\/10.1038\/nature08197.","journal-title":"Nature"},{"issue":"7029","key":"4019_CR107","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature03354","volume":"434","author":"JT Rodgers","year":"2005","unstructured":"Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of pgc-1alpha and sirt1. Nature. 2005;434(7029):113\u20138. https:\/\/doi.org\/10.1038\/nature03354.","journal-title":"Nature"},{"issue":"15","key":"4019_CR108","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.3390\/nu14153145","volume":"14","author":"R Tozzi","year":"2022","unstructured":"Tozzi R, Cipriani F, Masi D, Basciani S, Watanabe M, Lubrano C, et al. Ketone bodies and sirt1, synergic epigenetic regulators for metabolic health: a narrative review. Nutrients. 2022;14(15):3145. https:\/\/doi.org\/10.3390\/nu14153145.","journal-title":"Nutrients"},{"issue":"5666","key":"4019_CR109","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1126\/science.1094637","volume":"303","author":"A Brunet","year":"2004","unstructured":"Brunet A, Sweeney LB, Sturgill JF, Chua KF, Greer PL, Lin Y, et al. Stress-dependent regulation of foxo transcription factors by the sirt1 deacetylase. Science. 2004;303(5666):2011\u20135. https:\/\/doi.org\/10.1126\/science.1094637.","journal-title":"Science"},{"issue":"24","key":"4019_CR110","doi-asserted-by":"publisher","first-page":"7629","DOI":"10.3390\/molecules26247629","volume":"26","author":"R Alaaeldin","year":"2021","unstructured":"Alaaeldin R, Abdel-Rahman I, Hassan HA, Youssef N, Allam AE, Abdelwahab SF, et al. Carpachromene ameliorates insulin resistance in hepg2 cells via modulating ir\/irs1\/pi3k\/akt\/gsk3\/foxo1 pathway. Molecules. 2021;26(24):7629. https:\/\/doi.org\/10.3390\/molecules26247629.","journal-title":"Molecules"},{"issue":"24","key":"4019_CR111","doi-asserted-by":"publisher","first-page":"15860","DOI":"10.3390\/ijms232415860","volume":"23","author":"R Tozzi","year":"2022","unstructured":"Tozzi R, Campolo F, Baldini E, Venneri MA, Lubrano C, Ulisse S, et al. Ketogenic diet increases serum and white adipose tissue sirt1 expression in mice. Int J Mol Sci. 2022;23(24):15860. https:\/\/doi.org\/10.3390\/ijms232415860.","journal-title":"Int J Mol Sci"},{"key":"4019_CR112","doi-asserted-by":"publisher","first-page":"1443483","DOI":"10.3389\/fnut.2024.1443483","volume":"11","author":"S Kim","year":"2024","unstructured":"Kim S, Park D, Moon S, Gu B, Mantik KEK, Kwak H, et al. Ketogenic diet with aerobic exercise can induce fat browning: potential roles of \u03b2-hydroxybutyrate. Frontiers in Nutrition (Lausanne). 2024;11:1443483. https:\/\/doi.org\/10.3389\/fnut.2024.1443483.","journal-title":"Frontiers in Nutrition (Lausanne)"},{"key":"4019_CR113","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.mce.2016.11.013","volume":"455","author":"CL Moreno","year":"2017","unstructured":"Moreno CL, Mobbs CV. Epigenetic mechanisms underlying lifespan and age-related effects of dietary restriction and the ketogenic diet. Mol Cell Endocrinol. 2017;455:33\u201340. https:\/\/doi.org\/10.1016\/j.mce.2016.11.013.","journal-title":"Mol Cell Endocrinol"},{"key":"4019_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2021.108620","volume":"93","author":"D Li\u015bkiewicz","year":"2021","unstructured":"Li\u015bkiewicz D, Li\u015bkiewicz A, Grabowski M, Nowacka-Chmielewska MM, Jab\u0142o\u0144ska K, Wojakowska A, et al. Upregulation of hepatic autophagy under nutritional ketosis. J Nutr Biochem. 2021;93: 108620. https:\/\/doi.org\/10.1016\/j.jnutbio.2021.108620.","journal-title":"J Nutr Biochem"},{"issue":"4","key":"4019_CR115","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.18632\/aging.101838","volume":"11","author":"DH Kim","year":"2019","unstructured":"Kim DH, Park MH, Ha S, Bang EJ, Lee Y, Lee AK, et al. Anti-inflammatory action of beta-hydroxybutyrate via modulation of pgc-1alpha and foxo1, mimicking calorie restriction. Aging (Albany Ny). 2019;11(4):1283\u2013304. https:\/\/doi.org\/10.18632\/aging.101838.","journal-title":"Aging (Albany Ny)"},{"key":"4019_CR116","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.801303","volume":"13","author":"W Qi","year":"2022","unstructured":"Qi W, Hu C, Zhao D, Li X. Sirt1-sirt7 in diabetic kidney disease: biological functions and molecular mechanisms. Frontiers in Endocrinology (Lausanne). 2022;13: 801303. https:\/\/doi.org\/10.3389\/fendo.2022.801303.","journal-title":"Frontiers in Endocrinology (Lausanne)"},{"key":"4019_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101813","volume":"38","author":"HJ Sun","year":"2021","unstructured":"Sun HJ, Xiong SP, Cao X, Cao L, Zhu MY, Wu ZY, et al. Polysulfide-mediated sulfhydration of sirt1 prevents diabetic nephropathy by suppressing phosphorylation and acetylation of p65 nf-kappab and stat3. Redox Biol. 2021;38: 101813. https:\/\/doi.org\/10.1016\/j.redox.2020.101813.","journal-title":"Redox Biol"},{"issue":"7","key":"4019_CR118","doi-asserted-by":"publisher","first-page":"e3032","DOI":"10.1002\/dmrr.3032","volume":"34","author":"PST Suyoto","year":"2018","unstructured":"Suyoto PST. Effect of low-carbohydrate diet on markers of renal function in patients with type 2 diabetes: a meta-analysis. Diabetes Metab Res Rev. 2018;34(7):e3032. https:\/\/doi.org\/10.1002\/dmrr.3032.","journal-title":"Diabetes Metab Res Rev"},{"issue":"11","key":"4019_CR119","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.2215\/CJN.04010413","volume":"8","author":"AN Friedman","year":"2013","unstructured":"Friedman AN, Chambers M, Kamendulis LM, Temmerman J. Short-term changes after a weight reduction intervention in advanced diabetic nephropathy. Clin J Am Soc Nephrol. 2013;8(11):1892\u20138. https:\/\/doi.org\/10.2215\/CJN.04010413.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"2","key":"4019_CR120","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/nu12020333","volume":"12","author":"A Bruci","year":"2020","unstructured":"Bruci A, Tuccinardi D, Tozzi R, Balena A, Santucci S, Frontani R, et al. Very low-calorie ketogenic diet: a safe and effective tool for weight loss in patients with obesity and mild kidney failure. Nutrients. 2020;12(2):333. https:\/\/doi.org\/10.3390\/nu12020333.","journal-title":"Nutrients"},{"issue":"10","key":"4019_CR121","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258507","volume":"16","author":"NA Zainordin","year":"2021","unstructured":"Zainordin NA, Eddy Warman NA, Mohamad AF, Abu Yazid FA, Ismail NH, Chen XW, et al. Safety and efficacy of very low carbohydrate diet in patients with diabetic kidney disease\u2014a randomized controlled trial. PLoS ONE. 2021;16(10): e258507. https:\/\/doi.org\/10.1371\/journal.pone.0258507.","journal-title":"PLoS ONE"},{"issue":"4","key":"4019_CR122","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1007\/BF00270418","volume":"30","author":"R Trevisan","year":"1987","unstructured":"Trevisan R, Nosadini R, Fioretto P, Avogaro A, Duner E, Jori E, et al. Ketone bodies increase glomerular filtration rate in normal man and in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1987;30(4):214\u201321. https:\/\/doi.org\/10.1007\/BF00270418.","journal-title":"Diabetologia"},{"issue":"2","key":"4019_CR123","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1210\/jcem-65-2-331","volume":"65","author":"P Fioretto","year":"1987","unstructured":"Fioretto P, Trevisan R, Velussi M, Cernigoi A, De Riva C, Bressan M, et al. Glomerular filtration rate is increased in man by the infusion of both d, l-3-hydroxybutyric acid and sodium d, l-3-hydroxybutyrate. J Clin Endocrinol Metab. 1987;65(2):331. https:\/\/doi.org\/10.1210\/jcem-65-2-331.","journal-title":"J Clin Endocrinol Metab"},{"key":"4019_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5596125","volume":"2021","author":"Y Li","year":"2021","unstructured":"Li Y, Zhang Y, Shen X, Zhao F, Yan S. The value of ketone bodies in the evaluation of kidney function in patients with type 2 diabetes mellitus. J Diabetes Res. 2021;2021:1\u201308. https:\/\/doi.org\/10.1155\/2021\/5596125.","journal-title":"J Diabetes Res"},{"issue":"11","key":"4019_CR125","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.1111\/dom.15231","volume":"25","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wang J, Xu F, Zhang S, Cui S, Li Y, et al. A j-shaped relationship between ketones and the risk of diabetic kidney disease in patients with type 2 diabetes: new insights from a cross-sectional study. Diabetes Obes Metab. 2023;25(11):3317\u201326. https:\/\/doi.org\/10.1111\/dom.15231.","journal-title":"Diabetes Obes Metab"},{"issue":"12","key":"4019_CR126","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1093\/ckj\/sfad176","volume":"16","author":"C Zoccali","year":"2023","unstructured":"Zoccali C, Bellizzi V, Minutolo R, Mallamaci F, Conte G, De Nicola L. The effect of a ketogenic diet on weight loss in ckd: a randomized controlled trial in obese stage g1\u20133a ckd patients. Clin Kidney J. 2023;16(12):2309\u201313. https:\/\/doi.org\/10.1093\/ckj\/sfad176.","journal-title":"Clin Kidney J"},{"key":"4019_CR127","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.13997","author":"NS Mitchell","year":"2019","unstructured":"Mitchell NS, Scialla JJ, Yancy WS. Are low-carbohydrate diets safe in chronic or diabetic kidney disease? Ann N Y Acad Sci. 2019. https:\/\/doi.org\/10.1111\/nyas.13997.","journal-title":"Ann N Y Acad Sci"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04019-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04019-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04019-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T09:35:29Z","timestamp":1741340129000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04019-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":127,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4019"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04019-0","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]},"assertion":[{"value":"21 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"127"}}